JLK 

JLK, Inc., a South Korean enterprise, provides artificial intelligence-powered solutions to aid in patient diagnostics. The company's offerings span both AI medical and AI security applications. Its advanced AI platform delivers real-time, on-site services, integrating effortlessly with hospital infrastructure to fulfill the diagnostic needs of healthcare professionals. JLK's medical segment addresses a diverse array of conditions, supporting their management, treatment, and overall service. This includes a significant focus on neurological disorders like ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer's disease. Furthermore, the company extends its capabilities to lung diseases, coronary artery disease, prostate cancer, and digital pathology. Formerly known as JLK INSPECTION Co.,Ltd., JLK, Inc. is headquartered in Cheongju, South Korea.